The abstract is read at the publisher; the summary is JClub's.
Tryptophan catabolism drives AhR-dependent macropinocytosis and tumorigenesis in TSC2-deficient cells, with Trp increasing dextran uptake 2.8-fold and tumor volume dropping ~70–90% in vivo.
- Why it matters: TSC and LAM involve nutrient scavenging via macropinocytosis, but the specific extracellular nutrients and signaling pathway sustaining this process were unclear.
- What they did: In TSC2-deficient cells, Trp repletion increased dextran uptake 2.8-fold (p < 0.0001) and raised intracellular Trp 3.5-fold while lowering kynurenine by 60%; IDO1 inhibition blocked the response. AhR was constitutively nuclear and was reversed by rapamycin or CH-223191, and IDO1, TDO2, or AhR inhibition reduced macropinocytosis and proliferation.
- The result: AhR antagonism decreased glutathione by 70% and reduced tumor volume by ~70% with StemRegenin 1 and ~90% with CH-223191 (p < 0.0001), also lowering mTORC1 activity in TSC2-deficient tumors.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.